Viewing Study NCT06081894


Ignite Creation Date: 2025-12-25 @ 1:28 AM
Ignite Modification Date: 2025-12-27 @ 5:47 AM
Study NCT ID: NCT06081894
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-29
First Post: 2023-08-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic nHCM
Sponsor: Cytokinetics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module